Trials / Completed
CompletedNCT04669366
Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries
Treatment Patterns With Targeted Therapies in Metastatic Renal Cell Carcinoma (mRCC) in Sweden - A Retrospective Analysis of Data From National Registries
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,205 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study is to investigate treatment patterns and outcomes for Sutent and Inlyta in mRCC patients in a nationwide population-based setting in Sweden.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sunitinib | As provided in real world |
| DRUG | axitinib | As provided in real world |
Timeline
- Start date
- 2021-01-20
- Primary completion
- 2021-07-31
- Completion
- 2022-03-18
- First posted
- 2020-12-16
- Last updated
- 2024-07-19
- Results posted
- 2024-07-19
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04669366. Inclusion in this directory is not an endorsement.